World Journal of Pharmaceutical
and Medical Research

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical and Medical Research and Technology
An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)
ISSN (O) : 2455-3301
ISSN (P) : 3051-2557
IMPACT FACTOR: 7.533

ICV : 78.6

World Journal of Pharmaceutical and Medical Research (WJPMR) has indexed with various reputed international bodies like : Google Scholar , Index Copernicus , SOCOLAR, China , Indian Science Publications , Cosmos Impact Factor , Research Bible, Fuchu, Tokyo. JAPAN , Scientific Indexing Services (SIS) , UDLedge Science Citation Index , International Impact Factor Services , International Society for Research Activity (ISRA) Journal Impact Factor (JIF) , International Innovative Journal Impact Factor (IIJIF) , Scientific Journal Impact Factor (SJIF) , Global Impact Factor (In Process) , Digital Online Identifier-Database System (DOI-DS) , Science Library Index, Dubai, United Arab Emirates , Eurasian Scientific Journal Index (ESJI) , International Scientific Indexing, (ISI) UAE , IFSIJ Measure of Journal Quality , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Scope Database , Academia , Doi-Digital Online Identifier , ISSN National Centre , Zenodo Indexing , International CODEN Service, USA , 

Abstract

CLINICAL STUDY TO COMPARE THE HYPOGLYCEMIC EFFECT OF VIJAYSARGHANA VATI AND MAMAJJKAGHANA VATI IN MADHUMEHA~TYPE-2 DIABETES MELLITUS: PROTOCOL OF A CLINICAL COMPARATIVE STUDY

Kiran Chandolia*, Naimish Raj Singh

ABSTRACT

Background: Madhumeha is a condition described in Ayurveda which has been correlated with Type-2 Diabetes Mellitus. It is one of the types of Vataja Prameha. Describing the Prameha, it has been mentioned it is group of disorders in which there is increased frequency of micturition, the volume of urine is also increased and the urine becomes turbid. According to Acharya Charak, Madhumeha is also called Ojomeha. Aim and Objective: To compare the efficacy of Vijaysarghana Vati and Mamjjakghana Vati in Madhumeha~Type-2 Diabetes mellitus. Material and Method: This is a single-centre, open-label, randomized, comparative clinical study. Total 60 subjects in each group 30. Group A will receive Vijaysarghana Vati (500 mg, 2 tablets BD) and Group B will receive Mamajjakaghana Vati (500 mg, 2 tablets BD), both orally with plain water, empty stomach, 30 minutes before meals, for 90 days, followed by a 15-day follow-up. Outcomes will be assessed using fasting and postprandial blood glucose, HbA1c, and cardinal subjective symptoms of Madhumeha, recorded on Days 0, 1, 30, 60, 90 and at follow-up (Day 105). Expected Outcome: This study is expected to improvement in the biochemical parameters of Diabetes mellitus and clinical features of Madhumeha described in Ayurvedic texts

[Full Text Article]    [Download Certificate]

Powered By WJPMR | All Right Reserved

WJPMR